Cite
HARVARD Citation
Dilwali, S. et al. (n.d.). Preclinical validation of anti‐nuclear factor‐kappa B therapy to inhibit human vestibular schwannoma growth. Molecular oncology. 9 (7), pp. 1359-1370. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dilwali, S. et al. (n.d.). Preclinical validation of anti‐nuclear factor‐kappa B therapy to inhibit human vestibular schwannoma growth. Molecular oncology. 9 (7), pp. 1359-1370. [Online].